Article Details
Retrieved on: 2021-05-07 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... people under 40 should be offered an alternative to Oxford/AstraZeneca's COVID-19 shot where possible, due to a small risk from rare blood clots.
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here